首页 | 本学科首页   官方微博 | 高级检索  
检索        

美洛昔康栓剂治疗强直性脊柱炎62例
引用本文:郭军华,黄烽,张江林,杨春花,施桂英,吴东海,马丽,徐建华,帅宗文,徐胜前.美洛昔康栓剂治疗强直性脊柱炎62例[J].中国新药杂志,2003,12(9):757-760.
作者姓名:郭军华  黄烽  张江林  杨春花  施桂英  吴东海  马丽  徐建华  帅宗文  徐胜前
作者单位:1. 解放军总医院风湿科,北京,100853
2. 北京中日友好医院免疫风湿科,北京,100013
3. 安徽医科大学附属第一医院风湿科,合肥,230022
摘    要:目的:评价美洛昔康栓剂治疗强直性脊柱炎(AS)患者的疗效和安全性。方法:126例AS患者,随机分为治疗组62例和对照组64例,分别应用美洛昔康栓和美洛昔康片,剂量均为15mg·d~(-1),疗程6周。结果:治疗组与对照组的总有效率分别为84.49%和77.42%,2组比较差异无显著性(P>0.05),2组总计不良事件发生率分别为12.90%和21.87%,不良事件主要集中在胃肠道,无严重不良事件发生。结论:美洛昔康栓对AS患者的止痛效果及安全性与美洛昔康片类似,且总计不良事件发生率和单项最高不良事件发生率均低于片剂组。

关 键 词:美洛昔康  栓剂  强直性脊柱炎
文章编号:1003-3734(2003)09-0757-04

Efficacy and safety of meloxicam suppository in treatment of 62 cases of ankylosing spondylitis
GUO Jun-hua,HUANG Feng,ZHANG Jiang-lin,YANG Chun-hua,SHI Gui-ying,WU Dong-hai,MA Li,XU Jian-hua,SHUAI Zong-wen,XU Sheng-qian.Efficacy and safety of meloxicam suppository in treatment of 62 cases of ankylosing spondylitis[J].Chinese Journal of New Drugs,2003,12(9):757-760.
Authors:GUO Jun-hua  HUANG Feng  ZHANG Jiang-lin  YANG Chun-hua  SHI Gui-ying  WU Dong-hai  MA Li  XU Jian-hua  SHUAI Zong-wen  XU Sheng-qian
Abstract:Objective:To evaluate the efficacy and safety of meloxicam suppository in treatment of ankylosing spondylitis (AS) .Methods: 126 patients with AS were randomly divided to receive meloxicam suppository ( n = 62) or meloxicam tablets (n = 64) for 6 weeks.The dosage of two groups was both 15mg, qd. Results: The total effective rate was 84.49% for the suppository group and 77.42% for the tablets group.The total incidence of adverse events was 12.90% for the suppository group and 21.87% for the tablets group. Conclusion: The analgesic effect of meloxicam suppository in treatment of AS is similar to that of meloxicam tablets but with fewer adverse events.
Keywords:meloxicam  suppository  ankylosing spondylitis
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号